Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03677739 · ClinicalTrials.gov registry record · NA
Young Melanoma Family Facebook Intervention or Healthy Lifestyle Facebook Intervention in Improving Skin Examination in Participants With Melanoma and Their Families
A NA study of Clinical Stage III Cutaneous Melanoma AJCC v8 and Clinical Stage IA Cutaneous Melanoma AJCC v8, sponsored by Rutgers, The State University of New Jersey.
- Active
- Registry status
- NA
- Development phase
- 1,160
- Enrollment target
- 2
- Study locations
NCT03677739: Active NA study of Clinical Stage III Cutaneous Melanoma AJCC v8 and Clinical Stage IA Cutaneous Melanoma AJCC v8, sponsored by Rutgers, The State University of New Jersey.
NCT03677739 is a NA study of Clinical Stage III Cutaneous Melanoma AJCC v8 and Clinical Stage IA Cutaneous Melanoma AJCC v8 that is active but no longer recruiting, run by Rutgers, The State University of New Jersey. The registered enrollment target is 1,160 participants, above the 192-participant average among 23 other Clinical Stage III Cutaneous Melanoma AJCC v8 trials with a reported enrollment target (504% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03677739, a NA study of Clinical Stage III Cutaneous Melanoma AJCC v8 and Clinical Stage IA Cutaneous Melanoma AJCC v8, is active but no longer recruiting, sponsored by Rutgers, The State University of New Jersey.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 1,160 participants
- Enrollment target
- 2
- Study locations
Study Summary
This trial studies how well Young Melanoma Family Facebook intervention or Healthy Lifestyle Facebook intervention works in improving skin examination in participants with melanoma and their families. Young Melanoma Family Facebook intervention or Healthy Lifestyle Facebook intervention may help improve total cutaneous examinations, skin self-examinations, and sun protection among first degree relatives of young onset participants and the participants themselves.
Primary Outcome
Will be assessed as a binary response (yes/no) did participant have one
Conditions Studied
Interventions
- OTHER Survey Administration
- OTHER Informational Intervention
Study Locations (2)
New Jersey
- Rutgers Cancer Institute of New Jersey - New Brunswick
Texas
- MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,160 participants |
| Start Date | 2019-06-03 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
What the registry record for NCT03677739 still lists
NCT03677739 is an interventional study that assigns participants to a tested intervention. Its 1,160 participants enrollment target places it among the larger protocols in the corpus, above the 192-participant average among 23 other Clinical Stage III Cutaneous Melanoma AJCC v8 trials with a reported enrollment target (504% higher).
The record links to 10 conditions, with Clinical Stage III Cutaneous Melanoma AJCC v8 appearing as the primary indexed condition, and to 2 interventions - of which Survey Administration is the first listed.
NCT03677739 reports a single indexed study location in New Jersey, Texas.
Frequently Asked Questions
What is clinical trial NCT03677739 about?
NCT03677739 is a clinical study titled "Young Melanoma Family Facebook Intervention or Healthy Lifestyle Facebook Intervention in Improving Skin Examination in Participants With Melanoma and Their Families". This trial studies how well Young Melanoma Family Facebook intervention or Healthy Lifestyle Facebook intervention works in improving skin examination in participants with melanoma and their families. Young Melanoma Family Facebook intervention or Healthy Lifestyle Facebook intervention may help imp...
What is the current status of trial NCT03677739?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,160 participants. The study started on 2019-06-03. Estimated completion is 2025-12-31.
What conditions does trial NCT03677739 study?
This clinical trial studies the following conditions: Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma AJCC v8, Clinical Stage IB Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage II Cutaneous Melanoma AJCC v8.
What interventions are being tested in trial NCT03677739?
The interventions under investigation include: Survey Administration (OTHER), Informational Intervention (OTHER).
Who is sponsoring clinical trial NCT03677739?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03677739 being conducted?
This trial has 2 study locations across New Jersey, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Clinical Stage III Cutaneous Melanoma AJCC v8
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03677739's enrollment target sits among peer trials
1,160 2nd of 23 the highest of 23 other Clinical Stage III Cutaneous Melanoma AJCC v8 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Clinical Stage III Cutaneous Melanoma AJCC v8 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
RECRUITING · Phase 1
-
The Immune Effects of Fermented Wheat Germ Nutritional Supplementation in Patients With Advanced Solid Tumor Cancers Being Treated With Standard of Care Checkpoint Inhibitors
RECRUITING · Phase 1
-
Evaluation of Anti-PD-1 Therapy by Monitoring T Cell Responses in Melanoma, Lung and Other Cancer Types
RECRUITING
-
Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
RECRUITING · Phase 2
-
Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
RECRUITING · Phase 1
-
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04577599 · 1,160 participants · NA
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
- NCT07082738 · 1,160 participants · Phase 2
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- NCT07237048 · 1,164 participants · Phase 2
Minocycline in Stroke Study at Maimonides
- NCT07009509 · 1,166 participants · NA
Pilot Study of the YES-CAN! Program to Prevent Youth Nicotine Vaping
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI